Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant

  • Sylvia Adams
  • , David W. O'Neill
  • , Daisuke Nonaka
  • , Elizabeth Hardin
  • , Luis Chiriboga
  • , Kimberly Siu
  • , Crystal M. Cruz
  • , Angelica Angiulli
  • , Francesca Angiulli
  • , Erika Ritter
  • , Rose Marie Holman
  • , Richard L. Shapiro
  • , Russell S. Berman
  • , Natalie Berner
  • , Yongzhao Shao
  • , Olivier Manches
  • , Linda Pan
  • , Ralph R. Venhaus
  • , Eric W. Hoffman
  • , Achim Jungbluth
    • Sacha Gnjatic, Lloyd Old, Anna C. Pavlick, Nina Bhardwaj

Research output: Contribution to journal › Article › peer-review

238 Scopus citations

Fingerprint

Dive into the research topics of 'Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science